BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Staging
18 results:

  • 1. Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion.
    Le Saos-Patrinos C; Loizon S; Zouine A; Turpin D; Dilhuydy MS; Blanco P; Sisirak V; Forcade E; Duluc D
    J Leukoc Biol; 2023 Mar; 113(3):305-314. PubMed ID: 36807447
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epidermotropic B-Cell Lymphoma: A Case of Secondary Cutaneous Splenic Marginal Zone B-Cell Lymphoma With Autoinvolutive and Recurrent Cutaneous Lesions.
    Rovira-López R; Gallardo F; Salar A; Colomo L; Pujol RM
    Am J Dermatopathol; 2023 Feb; 45(2):81-85. PubMed ID: 36669069
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Application Value of Immunohistochemistry and Bone Marrow Morphology Detection in the Diagnosis and Clinical staging of Non-Hodgkin's Lymphoma].
    Hu N; Ding H; Chen L; Zhao HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):449-453. PubMed ID: 29665914
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical and cytogenetic characteristics of myeloma patients with overall survival less than 24 months].
    Zhuang J; Tang W; Li H; Chen M; Han B; Zhu T; Duan M; Li J; Zhang W; Xu Y; Wang S; Zhao Y; Zhou D
    Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):736-40. PubMed ID: 26080843
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A rare pediatric case of a thymic cytotoxic and lymphoblastic T/NK cell lymphoma.
    Gaiser T; Haedicke W; Becker MR
    Int J Clin Exp Pathol; 2010 Mar; 3(4):437-42. PubMed ID: 20490334
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aberrant positivity for cd79a in erythroid lineage cells--a finding observed in a subset of re-staging bone marrow trephine biopsies after treatment cell pain.
    Flora RS; Brito-Babapulle F; Naresh KN
    Haematologica; 2007 Jun; 92(6):855-6. PubMed ID: 17550863
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma].
    Usnarska-Zubkiewicz L; Mazur G; Wróbel T; Poreba M; Kuliczkowski K
    Pol Arch Med Wewn; 2003 Jul; 110(1):719-24. PubMed ID: 14682206
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of new patients with Bence-Jones, IgG and iga myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
    Braylan RC; Orfao A; Borowitz MJ; Davis BH
    Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system.
    Sirohi B; Powles R; Mehta J; Raje N; Kulkarni S; Ramiah V; Saso R; Horton C; Bhagwati N; Singhal S; Treleaven J
    Br J Haematol; 1999 Dec; 107(3):656-66. PubMed ID: 10583272
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3021-4. PubMed ID: 9329591
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic value of serum IL-6 level in monoclonal gammopathies.
    DuVillard L; Guiguet M; Casasnovas RO; Caillot D; Monnier-Zeller V; Bernard A; Guy H; Solary E
    Br J Haematol; 1995 Feb; 89(2):243-9. PubMed ID: 7873373
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia.
    Adami F; Guarini A; Pini M; Siviero F; Sancetta R; Massaia M; Trentin L; Foà R; Semenzato G
    Eur J Cancer; 1994; 30A(9):1259-63. PubMed ID: 7999409
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunogenetic analysis of bone marrow aspirates in patients with non-Hodgkin lymphomas.
    Ellison DJ; Hu E; Zovich D; Pinter-Brown L; Pattengale PK
    Am J Hematol; 1990 Mar; 33(3):160-6. PubMed ID: 2154093
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance.
    Rozman C; Montserrat E; Viñolas N
    Cancer; 1988 Jan; 61(2):279-83. PubMed ID: 2446736
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of the (A, B, C) staging and the Rai's staging from a large prospective series (935 patients). French Cooperative Group on Chronic Lymphocytic leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):363-7. PubMed ID: 3222146
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Therapy of chronic lymphocytic leukemia patients. Results from the French cooperative trials. French Cooperative Group on Chronic Lymphocytic leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):443-8. PubMed ID: 3065741
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical staging and immunological findings in chronic lymphocytic leukemia.
    Foa R; Catovsky D; Brozovic M; Marsh G; Ooyirilangkumaran T; Cherchi M; Galton DA
    Cancer; 1979 Aug; 44(2):483-7. PubMed ID: 314324
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.